Annals of Medicine and Surgery, 2022 · DOI: https://doi.org/10.1016/j.amsu.2022.103420 · Published: March 1, 2022
mRNA vaccines are a new type of vaccine used against COVID-19. While generally safe, they can sometimes cause unexpected skin reactions. This report describes a case where an elderly man developed a bullous pemphigoid, a blistering skin condition, shortly after receiving his second dose of the Pfizer COVID-19 vaccine. The patient was treated with corticosteroids and antibiotics and showed improvement, but later passed away due to a pulmonary embolism, potentially linked to his treatment.
Raise awareness among healthcare professionals about the potential dermatological side effects of mRNA COVID-19 vaccines, including bullous pemphigoid.
Encourage early diagnosis and prompt treatment of bullous pemphigoid following mRNA COVID-19 vaccination to improve patient outcomes.
Promote further research to understand the relationship between mRNA vaccines and bullous pemphigoid, including potential risk factors and mechanisms.